Summary
The FDA held a public hearing on psychedelic drugs, where doctors, veterans, pharmacists, and therapists advocated for clear safety and access standards for psychedelic-assisted therapies.
FDA Holds Public Hearing on Psychedelic Drugs as Trump-Driven Push Gains Momentum
HyperFast News
Related news
FDA Flags Massive Markups on Hospital Consumables; Mundhe Cites 2,841% Margin on IV Sets
19 Sept 2026, 10:58 am · News
FDA Approves Pancreatic Cancer Drug Rasonque, Potentially Doubling Survival Time
19 Sept 2026, 10:58 am · News
FDA to Decide on Loosening Peptide Production Rules This Week
19 Sept 2026, 10:58 am · News
